JP Morgan Private Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$2.28M	Sell	31,287 -9,747	-24%	-$779K	0.01%	695
2023 Q2	$3.41M	Sell	41,034 -87,238	-68%	-$7.3M	0.02%	420
2023 Q1	$9.78M	Sell	128,272 -44,218	-26%	-$3.67M	0.02%	431
2022 Q4	$14.3M	Sell	172,490 -73,448	-30%	-$5.95M	0.03%	358
2022 Q3	$19.5M	Buy	245,938 +57,914	+31%	+$4.88M	0.05%	287
2022 Q2	$14M	Buy	188,024 +70,636	+60%	+$5.3M	0.04%	345
2022 Q1	$10.6M	Buy	117,388 +4,120	+4%	+$380K	0.02%	431
2021 Q4	$12.7M	Sell	113,268 -23,746	-17%	-$2.86M	0.03%	394
2021 Q3	$17.2M	Buy	137,014 +3,116	+2%	+$401K	0.04%	334
2021 Q2	$18.1M	Buy	133,898 +12,128	+10%	+$1.59M	0.05%	322
2021 Q1	$16.5M	Buy	121,770 +9,344	+8%	+$1.4M	0.05%	304
2020 Q4	$15.8M	Buy	112,426 +1,300	+1%	+$167K	0.05%	299
2020 Q3	$12.4M	Sell	111,126 -388	-0.3%	-$43.5K	0.05%	294
2020 Q2	$12.5M	Buy	111,514 +27,502	+33%	+$2.71M	0.06%	255
2020 Q1	$6.51M	Buy	84,012 +2,748	+3%	+$243K	0.04%	317
2019 Q4	$7.73M	Buy	81,264 +7,375	+10%	+$638K	0.04%	343
2019 Q3	$5.63M	Buy	73,889 +5,679	+8%	+$472K	0.03%	380
2019 Q2	$5.98M	Sell	68,210 -1,057	-2%	-$90.2K	0.03%	350
2019 Q1	$6.27M	Sell	69,267 -345,709	-83%	-$29.4M	0.03%	354
2018 Q4	$29.8M	Sell	414,976 -108,353	-21%	-$8.73M	0.18%	130
2018 Q3	$50.2M	Buy	523,329 +8,257	+2%	+$801K	0.24%	96
2018 Q2	$49M	Buy	515,072 +75,665	+17%	+$6.95M	0.27%	84
2018 Q1	$38.5M	Buy	439,407 +2,143	+0.5%	+$196K	0.26%	94
2017 Q4	$37.1M	Buy	437,264 +28,519	+7%	+$2.39M	0.24%	104
2017 Q3	$35.4M	Buy	408,745 +29,852	+8%	+$2.39M	0.25%	103
2017 Q2	$29.2M	Buy	378,893 +40,372	+12%	+$2.86M	0.22%	109
2017 Q1	$23.5M	Buy	338,521 +134,282	+66%	+$9.02M	0.18%	130
2016 Q4	$12.1M	Buy	204,239 +108,805	+114%	+$6.72M	0.11%	182
2016 Q3	$6.33M	Sell	95,434 -227	-0.2%	-$14K	0.06%	250
2016 Q2	$5.17M	Sell	95,661 -5,372	-5%	-$294K	0.05%	261
2016 Q1	$5.22M	Sell	101,033 -30,736	-23%	-$1.6M	0.05%	245
2015 Q4	$9.25M	Sell	131,769 -14,106	-10%	-$962K	0.09%	184
2015 Q3	$9.08M	Sell	145,875 -23,832	-14%	-$1.88M	0.11%	168
2015 Q2	$14.3M	Sell	169,707 -10,278	-6%	-$799K	0.16%	147
2015 Q1	$13.5M	Sell	179,985 -6,015	-3%	-$420K	0.15%	148
2014 Q4	$11.6M	Buy	186,000 +3,810	+2%	+$217K	0.14%	161
2014 Q3	$9.47M	Buy	182,190 +828	+0.5%	+$42.2K	0.12%	181
2014 Q2	$9.31M	Sell	181,362 -31,485	-15%	-$1.42M	0.16%	143
2014 Q1	$10.1M	Buy	212,847 +8,805	+4%	+$451K	0.18%	132
2013 Q4	$8.86M	Buy	204,042 +9,750	+5%	+$404K	0.18%	137
2013 Q3	$8.37M	Sell	194,292 -675	-0.3%	-$27.3K	0.19%	137
2013 Q2	$6.78M	Buy	+194,967	New	+$6.85M	0.17%	141

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

JP Morgan Private Wealth Advisors's XBI Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 24% in Q3 2023, selling an estimated $779K and leaving 31,287 shares worth $2.28M. The position accounts for 0.01% of the portfolio, ranked #695.

JP Morgan Private Wealth Advisors first reported a position in XBI in Q2 2013 and has held it in 42 quarters since. The position peaked at $50.2M in Q3 2018. 679 funds tracked by Wall St. Rank hold XBI as of Q3 2023.

JP Morgan Private Wealth Advisors held 31,287 shares of State Street SPDR S&P Biotech ETF worth $2.28M as of Q3 2023.
JP Morgan Private Wealth Advisors sold 9,747 State Street SPDR S&P Biotech ETF shares in Q3 2023, an estimated $779K.
State Street SPDR S&P Biotech ETF made up 0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #695 holding.
JP Morgan Private Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 42 quarters since.
JP Morgan Private Wealth Advisors's State Street SPDR S&P Biotech ETF position peaked at $50.2M in Q3 2018.
679 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.